| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/18/2002 | WO2002029088A3 Highly expressible genes |
| 07/18/2002 | WO2002028351A3 Recombinant mucin binding proteins from steptococcus pneumoniae |
| 07/18/2002 | WO2002022776A3 Human coagulation factor vii variants |
| 07/18/2002 | WO2002012535B1 Use of anti-ceacam antibodies for stimulating b cells in the production of monoclonal antibodies or in immunotherapy |
| 07/18/2002 | WO2002010411A3 Preparation of a recombinant protein in a prokaryotic host cell by improved codon use |
| 07/18/2002 | WO2002006316A3 Alpha-msh related compounds and methods of use |
| 07/18/2002 | WO2002006311A3 Olfactory g-protein coupled receptor |
| 07/18/2002 | WO2002002633A3 Transporters and ion channels |
| 07/18/2002 | WO2001094391A3 Intracellular signaling proteins |
| 07/18/2002 | WO2001088132A3 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods |
| 07/18/2002 | WO2001087980A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 07/18/2002 | WO2001085798A3 Human monoclonal antibodies to dendritic cells |
| 07/18/2002 | WO2001085790A3 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 07/18/2002 | WO2001083749A3 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners |
| 07/18/2002 | WO2001083525A3 Modified peptides, comprising an fc domain, as therapeutic agents |
| 07/18/2002 | WO2001081590A3 Protein phosphatases |
| 07/18/2002 | WO2001081544A3 Identification and uses of a hyaluronan receptor |
| 07/18/2002 | WO2001081408A3 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 07/18/2002 | WO2001081377A3 Integrin/adhesion antagonists |
| 07/18/2002 | WO2001079468A3 Drug metabolizing enzymes |
| 07/18/2002 | WO2001079282A3 Molecules associated with human reproduction |
| 07/18/2002 | WO2001072822A3 Genes involved in intestinal inflammatory diseases and use thereof |
| 07/18/2002 | WO2001068705A3 Il-17 receptor like molecules and uses thereof |
| 07/18/2002 | WO2001051520A9 Nogo receptor-mediated blockade of axonal growth |
| 07/18/2002 | WO2001005834A9 Human tumor necrosis factor receptors tr13 and tr14 |
| 07/18/2002 | WO2000078972A9 Regulation with binding cassette transporter protein abc1 |
| 07/18/2002 | WO2000076310A9 Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions |
| 07/18/2002 | US20020095027 Polypeptide for use in the diagnosis and treatment of viral diseases in animals |
| 07/18/2002 | US20020095024 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 07/18/2002 | US20020094967 Polynucleotide |
| 07/18/2002 | US20020094955 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 07/18/2002 | US20020094954 Nucleic acids comprising the neuregulin-1-associated gene 1 (NRG1AG1) |
| 07/18/2002 | US20020094953 Nucleic acids, proteins, and antibodies |
| 07/18/2002 | US20020094530 Method to identify antibody targets |
| 07/18/2002 | US20020094340 Chlamydia antigens and corresponding dna thereof |
| 07/18/2002 | DE10123857A1 Verfahren zum Herstellen von heterologen Proteinen in einem homothallischen Pilz der Familie Sordariaceae A method for producing heterologous proteins in a homothallic fungus of the family Sordariaceae |
| 07/18/2002 | CA2436876A1 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 07/18/2002 | CA2434042A1 Asip-related proteins |
| 07/18/2002 | CA2433742A1 Proteins and nucleic acids encoding same |
| 07/18/2002 | CA2433687A1 Soluble cyclic analogues of beta amyloid peptide |
| 07/18/2002 | CA2430794A1 Human genes and gene expression products isolated from human prostate |
| 07/18/2002 | CA2429946A1 Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c |
| 07/17/2002 | EP1223214A1 Gene encoding novel human secretory phospholipase a 2? |
| 07/17/2002 | EP1222314A1 Human antibodies |
| 07/17/2002 | EP1222307A1 A pcam-1 marker protein, nucleic acid sequences encoding pcam-1 and immunoassays for detection of pcam-1 |
| 07/17/2002 | EP1222301A2 Protein production system |
| 07/17/2002 | EP1222298A1 Vectors and methods for recombinant protein expression |
| 07/17/2002 | EP1222286A2 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 07/17/2002 | EP1222281A2 Immunoligically significant herpes simplex virus antigens |
| 07/17/2002 | EP1222279A2 Growth factor polypeptides and nucleic acids encoding same |
| 07/17/2002 | EP1222277A2 Endozepine-like polypeptides and polynucleotides encoding same |
| 07/17/2002 | EP1222276A2 Polynucleotides and polypeptides encoded thereby |
| 07/17/2002 | EP1222275A2 Serum amyloid a isoform from colostrum |
| 07/17/2002 | EP1222274A2 Mage-a12 antigenic peptides and uses thereof |
| 07/17/2002 | EP1222273A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 07/17/2002 | EP1222270A2 Proteins and polynucleotides encoded thereby |
| 07/17/2002 | EP1222268A2 Vip54 protein and related materials |
| 07/17/2002 | EP1222267A2 Pcna-associated cell cycle proteins, compositions and methods of use |
| 07/17/2002 | EP1222264A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof |
| 07/17/2002 | EP1222253A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 07/17/2002 | EP1222211A1 Pcna associated cell cycle proteins, compositions and methods of use |
| 07/17/2002 | EP1222208A1 Polypeptide derivatives of parathyroid hormone (pth) |
| 07/17/2002 | EP1222207A1 C-peptide for the improved production of insulin and insulin analogues |
| 07/17/2002 | EP1222202A2 Ab5 toxin b subunit mutants with altered chemical conjug ation characteristics |
| 07/17/2002 | EP1221853A1 Oligodendrocyte cell cultures and methods for their preparation and use |
| 07/17/2002 | EP0815450B1 Compounds and methods for the dectection of t. cruzi infection |
| 07/17/2002 | EP0804219B1 Inhibin compositions and methods of use thereof |
| 07/17/2002 | CN1359424A Pesticidal fusions |
| 07/17/2002 | CN1359420A Novel indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals |
| 07/17/2002 | CN1359388A Method for enhanced protein stabilization and production of cell liell lines useful for production of such stabilized proteins |
| 07/17/2002 | CN1359298A Novel indications of mannan-bindie lectin (MBL) in the treatment of immanocompromised individuals |
| 07/16/2002 | US6420542 Tie ligands |
| 07/16/2002 | US6420540 Toxoplasma gondii antigens |
| 07/16/2002 | US6420532 Binding to human y2 receptors and expression |
| 07/16/2002 | US6420531 Polypeptides prepared by expressing in a host cell a dna code with amino acid sequence |
| 07/16/2002 | US6420530 Polymaleic acid polymer or copolymer with acrylic acid, maleic anhydride, ethyl acrylate or vinyl acetate |
| 07/16/2002 | US6420525 Human transcription factor ZGCL-1 |
| 07/16/2002 | US6420380 Hepatitis C inhibitor tri-peptides |
| 07/16/2002 | US6420353 Use of 7 α-substituted steroid to treat neuropsychiatric, immune or endocrine disorders |
| 07/16/2002 | US6420336 Purified antiviral protein, peptide or conjugate encoded by amino acid sequence 90% homologous to seq id no: 2; prophy-lactic or therapeutic inhibition of growth of a virus, such as a retrovirus; human immunodeficiency virus, hiv-1 or hiv-2 |
| 07/16/2002 | US6420175 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 07/16/2002 | US6420157 Expression vector coding enzymatic polypeptide for use in the treatment of inflammation and sexual disorders; for use in laundry detergents |
| 07/16/2002 | US6420155 Polypeptide for use in the treatment of cancer and atherosclerosis |
| 07/16/2002 | US6420152 Bacterial enzymatic polypeptide for use in detection of infection |
| 07/16/2002 | US6420140 Production of multimeric protein by cell fusion method |
| 07/16/2002 | US6420135 Streptococcus pneumoniae polynucleotides and sequences |
| 07/16/2002 | US6420134 Vaccines for nontypable haemophilus influenzae |
| 07/16/2002 | US6420124 KVLQT1—a long qt syndrome gene |
| 07/16/2002 | US6420113 Chimeric polyclonal antibodies |
| 07/16/2002 | US6419929 Genetic engineering |
| 07/16/2002 | US6419928 Monoclonal antibodies to transforming growth factor-beta and methods of use |
| 07/16/2002 | US6419925 Toxoplasma gondii antigens, the preparation thereof and the use thereof |
| 07/16/2002 | US6419921 DNA-constructs of blood clotting factors and P-Selectin |
| 07/16/2002 | US6419918 Receptors of chemotactic peptide; leukemia therapy |
| 07/16/2002 | CA2239360C G-csf analog compositions and methods |
| 07/16/2002 | CA2193094C The cytoplasmic inhibition of gene expression |
| 07/16/2002 | CA2097200C Protein tyrosine kinase |
| 07/16/2002 | CA2095926C Anti-human milk fat globule humanised antibodies |
| 07/16/2002 | CA2059242C Coleopteran-active bacillus thuringiensis isolate and a novel gene encoding a coleopteran-active toxin |
| 07/16/2002 | CA2024063C Antibodies directed against nerve growth factor-like peptides |